Bioventus Launches New Website for Knee Osteoarthritis Pain Relief Information

DURHAM, N.C.--()--In support of World Arthritis Day, which is celebrated every October 12 to raise awareness of arthritis, Bioventus, a global leader in orthobiologics, has launched a disease and product information website called OAKneePainRelief.com which combines information on knee osteoarthritis (OA) for both patients and health care providers (HCPs) with the full Bioventus portfolio of hyaluronic acid (HA)-based joint-fluid treatment options.

OA involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. Injection treatments of HA-based products, such as DUROLANE®, GELSYN-3®, and SUPARTZ FX® help manage knee OA pain. DUROLANE, is a single-injection, GELSYN-3, a three-injection, and SUPARTZ FX, a five-injection HA treatment for OA patients.

“OAKneePainRelief.com benefits both patients and HCPs. It provides patients with a wealth of information on OA including its causes and symptoms, as well as diagnosis and treatment options,” said Vivek Munshi, Vice President, Marketing, Bioventus. “Patients also have access to a physician locator tool where they can search for the nearest physician to learn more about HAs.”

HCPs will find OAKneePainRelief.com full of useful medical education which helps users stay current on the latest science and therapies with the goal of helping to improve patient care.

“HCPs can also expect an improved experience in doing business with Bioventus,” added Munshi. “OAKneePainRelief.com connects them to an online ordering and bill paying portal and to BV360, an online hub providing dedicated support to our customers throughout the reimbursement process.”

About Bioventus

Bioventus is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The orthobiologic products from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.BioventusGlobal.com and follow the company on Twitter @Bioventusglobal.

Bioventus, the Bioventus logo, and DUROLANE are registered trademarks and GELSYN-3 is a trademark of Bioventus LLC. SUPARTZ FX is a trademark of Seikagaku Corp.

Summary of Indications for Use:

DUROLANE is indicated for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen. Do not inject DUROLANE in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations. Risks can include transient pain or swelling at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Full prescribing information can be found in package insert, at DUROLANE.com, or by contacting Bioventus Customer Service at 1-800-836-4080.

GELSYN-3 is indicated for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g. acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site. GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site. Full prescribing information can be found in product labeling, at www.GELSYN3.com or by contacting customer service at 1-800-836-4080.

SUPARTZ FX is indicated for treatment of pain in osteoarthritis (osteoarthritis) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies avian (bird) products (feathers and eggs). SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site. Full prescribing information can be found in product labeling, at www.SupartzFX.com or by contacting customer service at 1-800-836-4080.

Contacts

Thomas Hill
919-474-6715
thomas.hill@bioventusglobal.com

Release Summary

Bioventus has launched a disease and product information website called OAKneePainRelief.com for patients and HCPs.

Contacts

Thomas Hill
919-474-6715
thomas.hill@bioventusglobal.com